Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FENOLDOPAM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Guzman, JA; Rosado, AE; Kruse, JA
      Dopamine-1 receptor stimulation attenuates the vasoconstrictive response to gut ischemia

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Chu, VL; Cheng, JWM
      Fenoldopam in the prevention of contrast media-induced acute renal failure

      ANNALS OF PHARMACOTHERAPY
    3. Halpenny, M; Lakshmi, S; O'Donnell, A; O'Callaghan-Enright, S; O'Connell, D; Shorten, G
      The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    4. Ikegami, H; Shishido, T; Ishida, K; Hanada, T; Nakayama, H; Doi, K
      Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    5. Louden, C; Morgan, DG
      Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entitiesfor human clinical trials

      PHARMACOLOGY & TOXICOLOGY
    6. Li, XX; Xu, J; Zheng, SP; Albrecht, FE; Robillard, JE; Eisner, GM; Jose, PA
      D-1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    7. Halpenny, M; Markos, F; Snow, HM; Duggan, PF; Gaffney, E; O'Connell, DP; Shorten, GD
      Effects of prophylactic fenoldopam infusion on renal blood flow and venal tubular function during acute hypovolemia in anesthetized dogs

      CRITICAL CARE MEDICINE
    8. Sladen, RN
      Will this magic bullet fly true?

      CRITICAL CARE MEDICINE
    9. Murphy, MB; Murray, C; Shorten, GD
      Drug therapy - Fenoldopam - A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension

      NEW ENGLAND JOURNAL OF MEDICINE
    10. Odlind, C; Fasching, A; Liss, P; Palm, F; Hansell, P
      Changing dopaminergic activity through different pathways: consequences for renal sodium excretion, regional blood flow and oxygen tension in the rat

      ACTA PHYSIOLOGICA SCANDINAVICA
    11. Yakazu, Y; Iwasawa, K; Narita, H; Kindscher, JD; Benson, KT; Goto, H
      Hemodynamic and sympathetic effects of fenoldopam and sodium nitroprusside

      ACTA ANAESTHESIOLOGICA SCANDINAVICA
    12. Tobias, JD
      Fenoldopam for controlled hypotension during spinal fusion in children andadolescents

      PAEDIATRIC ANAESTHESIA
    13. Tumlin, JA; Dunbar, LM; Oparil, S; Buckalew, V; Ram, CV; Mathur, V; Ellis, D; McGuire, D; Fellmann, J; Luther, RR
      Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial

      ACADEMIC EMERGENCY MEDICINE
    14. Sanada, H; Asico, LD; Shigetomi, S; Tanaka, K; Niimura, S; Watanabe, H; Goldstein, DS; Felder, RA
      The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    15. O'Connell, DP; Aherne, AM
      Renal dopaminergic mechanisms and hypertension: A chronology of advances

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    16. Venkatakrishnan, U; Chen, CJ; Lokhandwala, MF
      The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    17. Erstad, BL; Barletta, JF
      Treatment of hypertension in the perioperative patient

      ANNALS OF PHARMACOTHERAPY
    18. Murphy, MB
      Dopamine: a role in the pathogenesis and treatment of hypertension

      JOURNAL OF HUMAN HYPERTENSION
    19. Joseph, EC
      Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors andDA(1) agonists

      TOXICOLOGY LETTERS
    20. Halpenny, M; Markos, F; Snow, HM; Duggan, PF; Gaffney, E; O'Connell, DP; Shorten, GD
      The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs

      EUROPEAN JOURNAL OF ANAESTHESIOLOGY
    21. Newsholme, SJ; Thudium, DT; Gossett, KA; Watson, ES; Schwartz, LW
      Evaluation of plasma von Willebrand factor as a biomarker for acute arterial damage in rats

      TOXICOLOGIC PATHOLOGY
    22. Quevedo, M; Prieto, JC; Miranda, HF; Pinardi, G
      Isobolographic analysis of the interaction between fenoldopam and levodopaon arterial blood pressure of the rat

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    23. Teisman, ACH; Buikema, H; van Veldhuisen, FJ; de Zeeuw, D; van Gilst, WH
      Direct vasodilating effects of the new dopaminergic agonist Z1046 in humanarteries

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    24. Vaughan, CJ; Delanty, N
      Hypertensive emergencies

      LANCET
    25. Varon, J; Marik, PE
      The diagnosis and management of hypertensive crises

      CHEST
    26. Ng, SSW; Pang, CCY
      In vivo venodilator action of fenoldopam, a dopamine D-1-receptor agonist

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Brath, PC; MacGregor, DA; Ford, JG; Prielipp, RC
      Dopamine and intraocular pressure in critically ill patients

      ANESTHESIOLOGY
    28. Singh, NK; Goyal, RK
      New classes of antihypertensive drugs: Therapeutic potentials

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    29. Taylor, AA; Shepherd, AM; Polvino, W; Mangoo-Karim, R; Ballard, K; Sunthornyothin, S; Luther, RR; Pool, JL
      Prolonged fenoldopam infusions in patients with mild to moderate hypertension - Pharmacodynamic and pharmacokinetic effects

      AMERICAN JOURNAL OF HYPERTENSION
    30. Oparil, S; Aronson, S; Deeb, GM; Epstein, M; Levy, JH; Luther, RR; Prielipp, R; Taylor, A
      Fenoldopam: A new parenteral antihypertensive - Consensus roundtable on the management of perioperative hypertension and hypertensive crises

      AMERICAN JOURNAL OF HYPERTENSION
    31. QUEVEDO M; PRIETO JC; PEREZOLEA J
      THE EFFECT OF FENOLDOPAM ON THE BLOOD-PRESSURE OF THE RAT

      General pharmacology
    32. Jose, PA; Eisner, GM; Felder, RA
      Role of dopamine in the pathogenesis of hypertension

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    33. Albassam, MA; Metz, AL; Gragtmans, NJ; King, LM; Macallum, GE; Hallak, H; McGuire, EJ
      Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist

      TOXICOLOGIC PATHOLOGY
    34. de Vries, PAM; Navis, G; de Jong, PE; de Zeeuw, D
      Impaired renal vascular response to a D-1-like receptor agonist but not toan ACE inhibitor in conscious spontaneously hypertensive rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    35. Taylor, AA; Mangoo-Karim, R; Ballard, KD; Luther, RR; Pool, JL
      Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: A dose-tolerabilitystudy

      JOURNAL OF CLINICAL PHARMACOLOGY
    36. Mathur, VS; Swan, SK; Lambrecht, LJ; Anjum, S; Fellmann, J; McGuire, D; Epstein, M; Luther, RR
      The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects

      CRITICAL CARE MEDICINE
    37. Bakris, GL; Lass, NA; Glock, D
      Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors

      KIDNEY INTERNATIONAL
    38. Bales, A
      Hypertensive crisis - How to tell if it's an emergency or an urgency

      POSTGRADUATE MEDICINE
    39. Emerson, M; Paul, W; Page, CP
      Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit

      BRITISH JOURNAL OF PHARMACOLOGY
    40. Cooper, ZA; Mihm, FG
      Blood pressure control with fenoldopam during excision of a pheochromocytoma

      ANESTHESIOLOGY
    41. ASICO LD; EISNER GM; JOSE PA
      RENAL NERVES AND D-1-DOPAMINE RECEPTOR-MEDIATED NATRIURESIS

      Clinical and experimental hypertension
    42. SCHWIEGER IM; SCHIFFER ER; MOREL DR
      EFFECTS OF FENOLDOPAM ON SYSTEMIC AND SPLANCHNIC HEMODYNAMICS AND OXYGEN DELIVERY CONSUMPTION RELATIONSHIP DURING HYPERDYNAMIC OVINE ENDOTOXEMIA/

      Intensive care medicine
    43. Nyska, A; Herbert, RA; Chan, PC; Haseman, JK; Hailey, JR
      Theophylline-induced mesenteric periarteritis in F344/N rats

      ARCHIVES OF TOXICOLOGY
    44. GOLDBERG ME; LARIJANI GE
      PERIOPERATIVE HYPERTENSION

      Pharmacotherapy
    45. SINGER I; EPSTEIN M
      POTENTIAL OF DOPAMINE A-1 AGONISTS IN THE MANAGEMENT OF ACUTE-RENAL-FAILURE

      American journal of kidney diseases
    46. Hussain, T; Abdul-Wahab, R; Kotak, DK; Lokhandwala, MF
      Bromocriptine regulates angiotensin II response on sodium pump in proximaltubules

      HYPERTENSION
    47. OHMACHI Y; TORIUMI W; TAKASHIMA K; DOI K
      SYSTEMIC HISTOPATHOLOGY OF RATS TREATED WITH 6-SULFANILAMIDOINDAZOLE,A NOVEL ARTHRITOGENIC SULFONAMIDE

      Toxicologic pathology
    48. POST JB; FRISHMAN WH
      FENOLDOPAM - A NEW DOPAMINE AGONIST FOR THE TREATMENT OF HYPERTENSIVEURGENCIES AND EMERGENCIES

      Journal of clinical pharmacology
    49. BAUM M; QUIGLEY R
      INHIBITION OF PROXIMAL CONVOLUTED TUBULE TRANSPORT BY DOPAMINE

      Kidney international
    50. GOMBOTZ H; PLAZA J; MAHLA E; BERGER J; METZLER H
      DA(1)-RECEPTOR STIMULATION BY FENOLDOPAM IN THE TREATMENT OF POSTCARDIAC SURGICAL HYPERTENSION

      Acta anaesthesiologica Scandinavica
    51. PINTODOO PC; CHIBALIN AV; KATZ AI; SOARESDASILVA P; BERTORELLO AM
      SHORT-TERM VS SUSTAINED INHIBITION OF PROXIMAL TUBULE NA,K-ATPASE ACTIVITY BY DOPAMINE - CELLULAR MECHANISMS

      Clinical and experimental hypertension
    52. DUNCKER DJ; VANMEEGEN JR; VERDOUW PD
      CARDIOVASCULAR ACTIONS OF THE DOPAMINE-RECEPTOR AGONIST Z1046 IN SWINE

      Cardiovascular drugs and therapy
    53. YAMAGUCHI I; YAO L; SANADA H; OZONO R; MOURADIAN MM; JOSE PA; CAREY RM; FELDER RA
      DOPAMINE D-1A RECEPTORS AND RENIN RELEASE IN RAT JUXTAGLOMERULAR CELLS

      Hypertension
    54. KLECKER RW; COLLINS JM
      STEREOSELECTIVE METABOLISM OF FENOLDOPAM AND ITS METABOLITES IN HUMANLIVER-MICROSOMES, CYTOSOL, AND SLICES

      Journal of cardiovascular pharmacology
    55. CALHOUN D; OPARIL S; MATHUR V; LUTHER R; ELLIS D
      FENOLDOPAM - A NOVEL, PERIPHERALLY ACTING DOPAMINE-1 AGONIST FOR PARENTERAL TREATMENT OF HYPERTENSION

      Medicamentos de actualidad
    56. YATSU T; MIYAMOTO I; KANEKOTAKANUKI F; WATANABE T; TAKENAKA T
      PHARMACOLOGICAL AND PHARMACOKINETIC CHARACTERISTICS OF YM435, A NOVELDOPAMINE DA(1)-RECEPTOR AGONIST, IN ANESTHETIZED DOGS

      Journal of Pharmacy and Pharmacology
    57. EMERSON M; PAUL W; FERLENGA P; SEMERARO C; PAGE C
      EFFECTS OF DOPAMINE AND SELECTIVE DOPAMINE AGONISTS UPON PLATELET ACCUMULATION IN THE CEREBRAL AND PULMONARY VASCULATURE OF THE RABBIT

      British Journal of Pharmacology
    58. KRAUSE RS
      HYPERTENSIVE URGENCY CONCERN

      Academic emergency medicine
    59. PANACEK EA; DUNBAR LM
      HYPERTENSIVE URGENCY CONCERN - IN RESPONSE

      Academic emergency medicine
    60. HOEKSTRA JW
      HYPERTENSIVE URGENCY CONCERN - IN RESPONSE

      Academic emergency medicine
    61. SUN D; SCHAFER JA
      DOPAMINE INHIBITS AVP-DEPENDENT NA-4-LIKE RECEPTOR( TRANSPORT AND WATER PERMEABILITY IN RAT CCD VIA A D)

      American journal of physiology. Renal, fluid and electrolyte physiology
    62. VACHVANICHSANONG P; SELA S; SIDHU A
      ABSENCE OF DA(1) DA(2) DOPAMINE-RECEPTOR INTERACTIONS IN PROXIMAL TUBULES OF SPONTANEOUSLY HYPERTENSIVE RATS

      American journal of physiology. Renal, fluid and electrolyte physiology
    63. QIN FZ; WANG WZ; ZHAO RR
      EFFECTS OF DOPEXAMINE ON HEART FUNCTION OF ISOLATED HYPOXIC RABBIT HEART AND IN COMPARISON WITH FENOLDOPAM AND PROCATEROL

      Zhongguo yaoli xuebao
    64. JOSEPH EC; REES JA; DAYAN AD
      MESENTERIC ARTERIOPATHY IN THE RAT INDUCED BY PHOSPHODIESTERASE-III INHIBITORS - AN INVESTIGATION OF MORPHOLOGICAL, ULTRASTRUCTURAL, AND HEMODYNAMIC-CHANGES

      Toxicologic pathology
    65. PEARSON RJ; BARRINGTON KJ; JIRSCH DW; CHEUNG PY
      DOPAMINERGIC RECEPTOR-MEDIATED EFFECTS IN THE MESENTERIC VASCULATURE AND RENAL VASCULATURE OF THE CHRONICALLY INSTRUMENTED NEWBORN PIGLET

      Critical care medicine
    66. FRISHMAN WH; HOTCHKISS H
      SELECTIVE AND NONSELECTIVE DOPAMINE-RECEPTOR AGONISTS - AN INNOVATIVEAPPROACH TO CARDIOVASCULAR-DISEASE TREATMENT

      The American heart journal
    67. HOEKSTRA JW
      FENOLDOPAM FOR HYPERTENSIVE EMERGENCIES

      Academic emergency medicine
    68. PANACEK EA; BEDNARCZYK EM; DUNBAR LM; FOULKE GE; HOLCSLAW TL
      RANDOMIZED, PROSPECTIVE TRIAL OF FENOLDOPAM VS SODIUM-NITROPRUSSIDE IN THE TREATMENT OF ACUTE SEVERE HYPERTENSION

      Academic emergency medicine
    69. MARTIN SW; BROADLEY KJ
      ATYPICAL ANTAGONISM OF D-1-RECEPTOR-MEDIATED VASODILATOR RESPONSES INTHE PERFUSED KIDNEY BY SCH23390

      Pharmacological research
    70. ROSSI F; FORGIONE A
      PHARMACOTOXICOLOGICAL ASPECTS OF LEVOSULPIRIDE

      Pharmacological research
    71. KANSRA V; CHEN CJ; LOKHANDWALA MF
      DOPAMINE CAUSES STIMULATION OF PROTEIN-KINASE-C IN RAT RENAL PROXIMALTUBULES BY ACTIVATING DOPAMINE D-1 RECEPTORS

      European journal of pharmacology. Molecular pharmacology section
    72. JIN XH; WANG WZ; ZHAO RR
      COMPARISON OF THE CHARACTERISTICS AND DENSITY OF DOPAMINE-1 RECEPTORSIN MEMBRANES FROM DIFFERENT ARTERIES USING [H-3] SCH23390 BINDING

      Methods and findings in experimental and clinical pharmacology
    73. OHBU K; KASKEL FJ; KINOSHITA S; FELDER RA
      DOPAMINE-1 RECEPTORS IN THE PROXIMAL CONVOLUTED TUBULE OF DAHL RATS -DEFECTIVE COUPLING TO ADENYLATE-CYCLASE

      American journal of physiology. Regulatory, integrative and comparative physiology
    74. HANTON G; LENET JL; RUTY B; LEBLANC B
      CHARACTERIZATION OF THE ARTERITIS INDUCED BY INFUSION OF RATS WITH UK-61,260, AN INODILATOR, FOR 24 H - A COMPARISON WITH THE ARTERITIS INDUCED BY FENOLDOPAM MESYLATE

      Archives of toxicology
    75. ESTAN L; MARTINEZMIR I; RUBIO E; MORALESOLIVAS FJ
      NO EVIDENCE FOR DOPAMINE-INDUCED RELAXATION IN ISOLATED HUMAN MESENTERIC ARTERIAL STRIPS FROM ELDERLY PATIENTS

      General pharmacology
    76. GANGULY PK; MUKHERJEE K; SAHAI A
      RENAL DOPAMINE-RECEPTORS ARE INVOLVED IN THE DEVELOPMENT OF CARDIAC-HYPERTROPHY

      Molecular and cellular biochemistry
    77. RUMP LC; RIERAKNORRENSCHILD G; SCHWERTFEGER E; BOHMANN C; SPILLNER G; SCHOLLMEYER P
      DOPAMINERGIC AND ALPHA-ADRENERGIC CONTROL OF NEUROTRANSMISSION IN HUMAN RIGHT ATRIUM

      Journal of cardiovascular pharmacology
    78. LIEVERSE AG; VANVELDHUISEN DJ; SMIT AJ; ZIJLSTRA JG; MEIJER S; REITSMA WD; LIE KI; GIRBES ARJ
      RENAL AND SYSTEMIC HEMODYNAMIC-EFFECTS OF IBOPAMINE IN PATIENTS WITH MILD-TO-MODERATE CONGESTIVE-HEART-FAILURE

      Journal of cardiovascular pharmacology
    79. NOWICKI S; OCHOA EJ; LEVIN G; ELIAS MM
      INTRARENAL DOPAMINE PARTICIPATION IN FRUSEMIDE DIURETIC AND NATRIURETIC RESPONSES TO FRUSEMIDE

      Journal of autonomic pharmacology
    80. GERMANN R; HASIBEDER W; HAISJACKL M; SPARR H; LUZ G; PERNTHALER H; FRIESENECKER B; BONATTI J; GRUBER E; SCHWARZ B
      DOPAMINE-1-RECEPTOR STIMULATION AND MUCOSAL TISSUE OXYGENATION IN THEPORCINE JEJUNUM

      Critical care medicine
    81. LORENZ R; PASCHKE C; BORN P; CLEMENS R
      IN-VITRO EFFECTS OF THE SELECTIVE DOPAMINE 1-AGONIST FENOLDOPAM ON THE COAGULATION SYSTEM IN NATIVE WHOLE-BLOOD - COMPARISON TO DOPAMINE AND NITROPRUSSIDE

      Thrombosis research
    82. CHEN CJ; LOKHANDWALA MF
      POTENTIATION BY ENALAPRILAT OF FENOLDOPAM EVOKED NATRIURESIS IS DUE TO BLOCKADE OF INTRARENAL PRODUCTION OF ANGIOTENSIN-II IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    83. SCHIFFER ER; SCHWIEGER IM; GOSTELI P; POINSOT O; MENTHA G; MOREL DR
      SYSTEMIC AND SPLANCHNIC OXYGEN SUPPLY-DEMAND RELATIONSHIP WITH FENOLDOPAM, DOPAMINE AND NORADRENALINE IN SHEEP

      European journal of pharmacology
    84. MARTIN SW; BROADLEY KJ
      RENAL VASODILATATION BY DOPEXAMINE AND FENOLDOPAM DUE TO ALPHA(1)-ADRENOCEPTOR BLOCKADE

      British Journal of Pharmacology
    85. HENNES HJ; JANTZEN JPAH
      EFFECTS OF FENOLDOPAM ON INTRACRANIAL-PRESSURE AND HEMODYNAMIC VARIABLES AT NORMAL AND ELEVATED INTRACRANIAL-PRESSURE IN ANESTHETIZED PIGS

      Journal of neurosurgical anesthesiology
    86. WANG WZ; ZHAO RR; QIN FZ
      COMPARISON OF THE EFFECTS OF DOPAMINE(1)-RECEPTOR AND DOPAMINE(2)-RECEPTOR AGONISTS ON THE CAMP GENERATING-SYSTEM IN CANINE CORONARY-ARTERIES AND RENAL-ARTERIES

      Methods and findings in experimental and clinical pharmacology
    87. KAPLAN NM
      MANAGEMENT OF HYPERTENSIVE EMERGENCIES

      Lancet
    88. POLAK MJ; TAYLOR DA
      FUNCTIONAL ONTOGENY OF PULMONARY VASCULAR DA(1) DOPAMINE-RECEPTORS INTHE ISOLATED-PERFUSED RABBIT LUNG

      Pediatric research
    89. JACINTO SM; LOKHANDWALA MF; JANDHYALA BS
      STUDIES ON THE PHARMACOLOGICAL INTERVENTIONS TO PREVENT OXYGEN-FREE RADICAL (OFR)-MEDIATED TOXICITY - EFFECTS OF DOPEXAMINE, A DA(1) RECEPTOR AND BETA(2) ADRENOCEPTOR AGONIST

      Naunyn-Schmiedeberg's archives of pharmacology
    90. CHRISTIE MI; SMITH GW
      CARDIOVASCULAR AND RENAL HEMODYNAMIC-EFFECTS OF A-68930 IN THE CONSCIOUS DOG - A COMPARISON WITH FENOLDOPAM

      The Journal of pharmacology and experimental therapeutics
    91. BUGHI S; JOSTVU E; ANTONIPILLAI I; NADLER J; HORTON R
      EFFECT OF DOPAMINE(2) BLOCKADE ON RENAL-FUNCTION UNDER VARIED SODIUM-INTAKE

      The Journal of clinical endocrinology and metabolism
    92. DRIEMAN JC; VANKAN FJPM; THIJSSEN HHW; VANESSEN H; SMITS JFM; BOUDIER HAJS
      REGIONAL HEMODYNAMIC-EFFECTS OF DOPAMINE AND ITS PRODRUGS L-DOPA AND GLUDOPA IN THE RAT AND IN THE GLYCEROL-TREATED RAT AS A MODEL FOR ACUTE-RENAL-FAILURE

      British Journal of Pharmacology
    93. DHASMANA KM; VILLALON CM; ZHU YN; PARMAR SS
      THE ROLE OF DOPAMINE (D2), ALPHA-ADRENOCEPTOR AND BETA-ADRENOCEPTOR RECEPTORS IN THE DECREASE IN GASTROINTESTINAL TRANSIT INDUCED BY DOPAMINE AND DOPAMINE-RELATED DRUGS IN THE RAT

      Pharmacological research
    94. GOLDBERG ME; CANTILLO J; NEMIROFF MS; SUBRAMONI J; MUNOZ R; TORJMAN M; SCHIEREN H
      FENOLDOPAM INFUSION FOR THE TREATMENT OF POSTOPERATIVE HYPERTENSION

      Journal of clinical anesthesia
    95. BODMANN KF; TROSTER S; CLEMENS R; SCHUSTER HP
      HEMODYNAMIC PROFILE OF INTRAVENOUS FENOLDOPAM IN PATIENTS WITH HYPERTENSIVE CRISIS

      The Clinical investigator
    96. WANG YX; BROOKS DP
      EFFECT OF DIETARY-PROTEIN ON THE RENAL RESPONSE TO FENOLDOPAM IN DIABETIC RATS

      European journal of pharmacology. Environmental toxicology and pharmacology section
    97. PATEL JJ; MITHA AS; SARELI P; DEVAAL JB
      INTRAVENOUS FENOLDOPAM INFUSION IN SEVERE HEART-FAILURE

      Cardiovascular drugs and therapy
    98. ROBLES RG; VILLA E; ANDRES A; MARTINEZ J; RUILOPE LM; SANCHO JM
      NATRIURETIC EFFECTS OF DOPAMINE AGONIST DRUGS IN MODELS OF REDUCED RENAL MASS

      Journal of cardiovascular pharmacology
    99. PILMER BL; GREEN JA; PANACEK EA; ELLIOT WJ; MURPHY MB; RUTHERFORD W; NARA AR
      FENOLDOPAM MESYLATE VERSUS SODIUM-NITROPRUSSIDE IN THE ACUTE MANAGEMENT OF SEVERE SYSTEMIC HYPERTENSION

      Journal of clinical pharmacology
    100. DAWSON R; FELHEIM R; PHILLIPS MI
      DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS BOTH INHIBIT DOPAMINE SECRETION IN LLC-PK(1) CELLS

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 15:29:24